EUVIMEDEUVIMED entdecken
Crossref

A novel cDNA‐uPA/SCID/Rag2 −/− /Jak3 −/− mouse model for hepatitis virus infection and reconstruction of human immune system

Takuro Uchida iD, Yuji Teraoka, Michio Imamura iD, Hiromi Abe-Chayama, Grace Naswa Makokha, Clair Nelson Hayes, Hiroshi Aikata iD, Satoko Hamamura, Yuji Ishida, Chise Tateno, Takayuki Shirouzu, Shintaro Kawai und 4 weitere

Journal of Viral Hepatitis · 2023

DOI: 10.1111/jvh.13793 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2023. Verfasst von Takuro Uchida und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Hepatitis C, Hepatitis Viruses. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although human hepatocyte‐transplanted immunodeficient mice support infection with hepatitis viruses, these mice fail to develop viral hepatitis due to the lack of an adaptive immune system. In this study, we generated new immunodeficiency cDNA‐urokinase‐type plasminogen activator (uPA)/SCID/Rag2 −/− /Jak3 −/− mice and established a mouse model with both a humanized liver and immune system. Transplantation of human hepatocytes with human leukocyte antigen (HLA)‐A24 resulted in establishment of a highly replaced liver in cDNA‐uPA/SCID/Rag2 −/− /Jak3 −/− mice. These mice were successfully infected with hepatitis B virus (HBV) and hepatitis C virus (HCV) for a prolonged period and facilitate analysis of the effect of anti‐HCV drugs. Administration of peripheral blood mononuclear cells (PBMCs) obtained from an HLA‐A24 donor resulted in establishment of 22.6%–81.3% human CD45‐positive mononuclear cell chimerism in liver‐infiltrating cells without causing graft‐versus‐host disease in cDNA‐uPA/SCID/Rag2 −/− /Jak3 −/− mice without human hepatocyte transplantation. When mice were transplanted with human hepatocytes and then administered HLA‐A24‐positive human PBMCs, an alloimmune response between transplanted human hepatocytes and PBMCs occurred, with production of transplanted hepatocyte‐specific anti‐HLA antibody. In conclusion, we succeeded in establishing a humanized liver/immune system characterized by an allo‐reaction between transplanted human immune cells and human liver using a novel cDNA‐uPA/SCID/Rag2 −/− /Jak3 −/− mouse. This mouse model can be used to generate a chronic hepatitis mouse model with a human immune system with application not only to hepatitis virus virology but also to investigation of the pathology of post‐transplantation liver rejection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CHepatitis VirusesAnimalsHumansMiceDisease Models, AnimalDNA, ComplementaryHepacivirusHepatocytesHLA-A24 AntigenJanus Kinase 3Leukocytes, MononuclearLiverMice, SCIDMice, TransgenicUrokinase-Type Plasminogen ActivatorDNA-Binding ProteinsNuclear Proteins

Stichwörter der Autor:innen

HBVHCVhuman hepatocyte chimeric micehuman leukocyte antigenhumanized mice

Substanzen

DNA, ComplementaryHLA-A24 AntigenJanus Kinase 3Urokinase-Type Plasminogen ActivatorJAK3 protein, humanRAG2 protein, humanDNA-Binding ProteinsNuclear ProteinsRag2 protein, mouse

Autor:innen und Institutionen

  • Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Research Center for Hepatology and Gastroenterology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.
  • Center for Medical Specialist Graduate Education and Research, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • PhoenixBio Co., Ltd., Higashihiroshima, Japan.
  • Molecular Diagnostics Division, Wakunaga Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

ORCID-Profile: Takuro Uchida, Michio Imamura, Hiroshi Aikata, Kazuaki Chayama

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Uchida, T., Teraoka, Y., Imamura, M., Abe-Chayama, H., Makokha, G. N., Hayes, C. N., Aikata, H., Hamamura, S., Ishida, Y., Tateno, C., Shirouzu, T., Kawai, S., Tanaka, Y., Ohdan, H., Okada, S., & Chayama, K. (2023). A novel cDNA‐uPA/SCID/Rag2 −/− /Jak3 −/− mouse model for hepatitis virus infection and reconstruction of human immune system. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13793

Vancouver

Uchida T, Teraoka Y, Imamura M, Abe-Chayama H, Makokha GN, Hayes CN, et al. A novel cDNA‐uPA/SCID/Rag2 −/− /Jak3 −/− mouse model for hepatitis virus infection and reconstruction of human immune system. Journal of Viral Hepatitis. 2023. doi:10.1111/jvh.13793

BibTeX
@article{Uchida2023,
  author = {Uchida, Takuro and Teraoka, Yuji and Imamura, Michio and Abe-Chayama, Hiromi and Makokha, Grace Naswa and Hayes, Clair Nelson and Aikata, Hiroshi and Hamamura, Satoko and Ishida, Yuji and Tateno, Chise and Shirouzu, Takayuki and Kawai, Shintaro and Tanaka, Yuka and Ohdan, Hideki and Okada, Seiji and Chayama, Kazuaki},
  title = {A novel cDNA‐uPA/SCID/Rag2 −/− /Jak3 −/− mouse model for hepatitis virus infection and reconstruction of human immune system},
  journal = {Journal of Viral Hepatitis},
  year = {2023},
  doi = {10.1111/jvh.13793}
}
Kostenlos starten →